Skip to main content

Advertisement

Log in

In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Platelet function might play an essential role in the pathogenesis of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH). Thus, impaired platelet function and disturbed primary haemostasis induced by intake of acetylsalicylic acid (ASA) might influence the rate of DCI. Primary haemostasis and platelet function can be measured with in vitro diagnosis (platelet function analyser test, PFA 100). The aim of this study is to evaluate the rate of DCI, haemorrhagic complications and the neurological outcome. Two groups were compared (patients with regular platelet function versus patients with impaired platelet function). This is a retrospective observational study. An initial cohort of 787 patients with SAH has been treated from January 2005 to September 2012. Seventy-nine patients (10%) with aneurysmal SAH, a history of ASA medication and PFA testing within the first 24 h after aneurysm rupture have been included. The overall rate of DCI in the present study was 43%. In vitro platelet function testing showed pathological primary haemostasis in 69.6%. The DCI rate was higher in patients with regular tested primary haemostasis (p = 0.02, OR = 3.16, 95%CI = [1.19; 8.83]). However, outcome assessment by mGOS did not show a significant difference between the groups. Patients with impaired primary haemostasis did not display a higher rate of haemorrhagic complications. Impairment of primary haemostasis resulting from an impairment of platelet function at an early stage after SAH might lead to a lower rate of DCI. In vitro testing of platelet function might be useful to predict the occurrence of DCI in the course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dorsch NW, King MT (1994) A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: incidence and effects. J Clin Neurosci 1(1):19–26

    Article  CAS  PubMed  Google Scholar 

  2. Macdonald RL (2013) Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10(1):44–58

    Article  PubMed  Google Scholar 

  3. Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KTS (2012) Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109(3):315–329

    Article  CAS  PubMed  Google Scholar 

  4. Dumont AS, Dumont RJ, Chow MM et al (2003) Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53(1):123–135 discussion 1545-1546

    Article  PubMed  Google Scholar 

  5. de Gaetano G, Cerletti C, Nanni-Costa MP, Poggi A (1989) The blood platelet as an inflammatory cell. Eur Respir J Suppl 6:441s–445s

    PubMed  Google Scholar 

  6. Projahn D, Koenen RR (2012) Platelets: key players in vascular inflammation. J Leukoc Biol 92(6):1167–1175

    Article  CAS  PubMed  Google Scholar 

  7. Huang H-S, Chang H-H (2012) Platelets in inflammation and immune modulations: functions beyond hemostasis. Arch Immunol Ther Exp 60(6):443–451

    Article  CAS  Google Scholar 

  8. O’Brien M (2012) The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med 27(2):46–52

    Article  PubMed  Google Scholar 

  9. Duerschmied D, Suidan GL, Demers M et al (2013) Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 121(6):1008–1015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Boulaftali Y, Hess PR, Getz TM (2013) Platelet {ITAM} signaling is critical for vascular integrity in inflammation. J Clin Invest 5(28):1–9

    Google Scholar 

  11. Juvela S, Hillbom M, Kaste M (1991) Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74(3):386–392

    Article  CAS  PubMed  Google Scholar 

  12. Juvela S, Ohman J, Servo A, Heiskanen O, Kaste M (1991) Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. Stroke 22(4):451–455

    Article  CAS  PubMed  Google Scholar 

  13. Ohkuma H, Ogane K, Fujita S, Manabe H, Suzuki S (1993) Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke 24(10):1541–1545 discussion 1545-1546

    Article  CAS  PubMed  Google Scholar 

  14. Picker SM (2011) In-vitro assessment of platelet function. Transfus Apher Sci 44(3):305–319

    Article  PubMed  Google Scholar 

  15. Juvela S (1995) Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 82(6):945–952

    Article  CAS  PubMed  Google Scholar 

  16. Dorhout Mees SM, Rinkel GJE, Feigin VL et al (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 3:CD000277

    Google Scholar 

  17. Toussaint LG, Friedman JA, Wijdicks EFM et al (2004) Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg 101(6):921–925

    Article  CAS  PubMed  Google Scholar 

  18. van den Bergh WM, Algra A, Dorhout Mees SM et al (2006) Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the {MASH} study. Stroke 37(9):2326–2330

    Article  PubMed  Google Scholar 

  19. Börgermann J, Kanashnik A, Sossdorf M, Gummert J, Lösche W (2010) Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery. Platelets 21(8):610–615

    Article  PubMed  Google Scholar 

  20. Vergouwen MDI, Vermeulen M, van Gijn J et al (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41(10):2391–2395

    Article  PubMed  Google Scholar 

  21. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA (1995) Description of an in vitro platelet function {analyzer–PFA-100.}. Semin Thromb Hemost 21(Suppl 2):106–112

    PubMed  Google Scholar 

  22. Kratzer MA, Born GV (1985) Simulation of primary haemostasis in vitro. Haemostasis 15(6):357–362

    CAS  PubMed  Google Scholar 

  23. Mammen EF, Comp PC, Gosselin R et al (1998) {PFA-100} system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24(2):195–202

    Article  CAS  PubMed  Google Scholar 

  24. Hayward CPM, Harrison P, Cattaneo M, Ortel TL, Rao AK (2006) Platelet function analyzer ({PFA)-100} closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost {JTH} 4(2):312–319

    Article  CAS  PubMed  Google Scholar 

  25. Spencer MP, Reid JM Quantitation of carotid stenosis with continuous-wave (C-W) Doppler ultrasound. Stroke 10(3):326–330

  26. Friedrich V, Bederson JB, Sehba FA (2013) Gender influences the initial impact of subarachnoid hemorrhage: an experimental investigation. PLoS One 8(11):e80101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Jenne CN, Urrutia R, Kubes P (2013) Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 35(3):254–261

    Article  CAS  PubMed  Google Scholar 

  28. Pluta RM, Hansen-Schwartz J, Dreier J et al (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31(2):151–158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yu Y, Qin J, Liu M, Ruan Q, Li Y, Zhang Z (2014) Role of rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability. Int J Mol Med 33(3):661–669

    Article  CAS  PubMed  Google Scholar 

  30. Jones LD, Jackson JW, Maggirwar SB (2016) Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction. PLoS One 11(3):e0151702

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 4:CD006184

    Google Scholar 

  32. Stienen MN, Smoll NR, Weisshaupt R et al (2014) Delayed cerebral ischemia predicts neurocognitive impairment following aneurysmal subarachnoid hemorrhage. World Neurosurg 82(5):e599–e605

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian von der Brelie.

Ethics declarations

The manuscript was prepared in accordance with the declaration of Helsinki.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

von der Brelie, C., Subai, A., Limperger, V. et al. In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage. Neurosurg Rev 41, 531–538 (2018). https://doi.org/10.1007/s10143-017-0885-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-017-0885-1

Keywords

Navigation